Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: If each potential infringer has been given a ballpark figure for a license,

Here is some food for thought. Wasn't someone talking to one of our CEO's at a shareholders meeting, sometime after the J3 settlement, and the comment was made that the J's just were not infringing that much. What is the difference between when the J's trial first started and then, and also now with the T3 (T2).

I can't see us spending 13 million in legal fees to pursue companies that were not infringing that much. So, IMO, something happened at the j's trial to let them off the hook big-time. Perhaps the chip families Vs Chips fiasco had a major effect.

Share
New Message
Please login to post a reply